Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China
Open Access
- 6 August 2019
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 8 (12) , 5787-5799
Abstract
Background: Liver cancer is a commonly diagnosed malignancy in China. The etiologies of liver cancer are widely known, although studies on temporal trends in liver cancer caused by specific etiologies are rare.Methods: Data on the incidence and mortality of liver cancer were retrieved from the Global Burden of Diseases Study 2017. The estimated annual percentage change (EAPC) was used to quantify temporal trends in the age‐standardized incidence rate (ASIR) and the age‐standardized mortality rate (ASMR) of liver cancer from 1990 to 2017.Results: Nationwide, the number of incident cases of liver cancer increased from 258 000 in 1990 to 515 900 in 2017. The ASIR decreased from 27.16 per 100 000 to 26.04 per 100 000 during this period, with an EAPC of −0.64 (95% confidence interval [CI] −0.84, −0.44). The number of deaths increased from 245 300 in 1990 to 418 200 in 2017, and the ASMR decreased from 26.72 to 21.30 (EAPC = −1.16, 95% CI −1.35, −0.97). The most pronounced decreases in the ASIR and ASMR were observed in liver cancer due to hepatitis B and in people aged 15‐49 years.Conclusions: Since the extensive efforts for prevention of hepatitis B virus infection, the incidence of liver cancer due to hepatitis B has significantly decreased. However, liver cancer due to hepatitis C, NASH, and other causes remains a major public health concern. Additional preventive strategies tailored to liver cancer are needed to further reduce its disease burden in China.Keywords
Funding Information
- Science and Technology Commission of Shanghai Municipality (16JC1400500)
This publication has 48 references indexed in Scilit:
- NAFLD leads to liver cancer: Do we have sufficient evidence?Cancer Letters, 2014
- NAFLD, NASH and liver cancerNature Reviews Gastroenterology & Hepatology, 2013
- Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of ChinaCarcinogenesis, 2013
- Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year periodInternational Journal of Infectious Diseases, 2012
- Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976–2005European Journal of Epidemiology, 2011
- Liver cancer epidemic in China: Past, present and futureSeminars in Cancer Biology, 2011
- Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infectionCancer Letters, 2009
- Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccinationVaccine, 2009